Lee S. Cohen, MD

Ammon-Pinizzotto Center for Women’s Mental Health, Massachusetts General Hospital, Boston, Massachusetts

JCP
Enhancing Postpartum Psychosis Care
Commentary

May 29, 2024

The authors discuss the need for qualitative research to fill gaps in the current understanding of postpartum psychosis, as well as the barriers that make conducting this research a...
Lauren A. Kobylski, Huynh-Nhu Le, Marlene P. Freeman, et al
JCP
Effects of Prenatal Exposure to Second-Generation Antipsychotics on Development and Behavior in Preschool-Aged Children
Original Research

March 13, 2024

Outcomes of children exposed in utero to second-generation antipsychotics (SGAs) were compared to those of children unexposed to SGAs in a cohort of mothers with a history of psychiatric...
Carol Swetlik, Lee S. Cohen, Lauren A. Kobylski, et al
JCP
Research Participant Feedback on a Suicide Safety Protocol
Original Research

May 15, 2023

In women who triggered a safety protocol as part of a perinatal suicidal ideation study, 50% reported that the protocol increased engagement with treatment, and most reported a “positive...
Rachel Vanderkruik, Marlene P. Freeman, Katherine A. Dunn, et al
JCP
In Memoriam: Joseph Biederman, MD
In Memoriam

February 22, 2023

Colleagues and friends remember Joseph Biederman and reflect on his legacy as the father of pediatric psychopharmacology.
Timothy E. Wilens, Janet R. Wozniak, Lee S. Cohen, et al
JCP
Risk of PNAS in SGA-Exposed Infants
Original Research

January 4, 2023

Roughly 30% of infants exposed to SGAs in utero exhibited poor neonatal adaptation syndrome; the percentage among antidepressant-exposed infants was similar.
Adele C. Viguera, Sara A. McElheny, Phoebe S. Caplin, et al
JCP
Correction

October 5, 2021

Adele C. Viguera, Marlene P. Freeman, Lina Góez-Mogollón, et al
JCP
Reproductive Safety of Second-Generation Antipsychotics
Original Research

August 3, 2021

What do data from a pregnancy registry demonstrate about the risk of major malformations among infants exposed to second-generation antipsychotics during the first trimester?
Adele C. Viguera, Marlene P. Freeman, Lina Góez-Mogollón, et al
JCP
Commentary

May 12, 2020

This commentary notes the findings and implications of a recent study by Rommel et al and discusses possible risks of perinatal antidepressant treatment in light of the need to...
Ruta M. Nonacs, Lee S. Cohen
JCP
Perspectives on the New FDA Pregnancy and Lactation Labeling Rule
Academic Highlights

July 17, 2018

Pregnancy labeling of prescription medications in the US is in the midst of a major transformation. Are you aware of the changes? Read this summary of a recent conference...
Marlene P. Freeman, Tiffany Farchione, Lynn Yao, et al
JCP
Original Research

March 14, 2017

Women with a history of depression are particularly vulnerable to depression in the postpartum period. Are there ways that physicians can predict which previously depressed women may develop postpartum...
Rita Suri, Zachary N. Stowe, Lee S. Cohen, et al
JCP
Article

April 22, 2015

Lee S. Cohen, Adele C. Viguera, Kathryn A. McInerney, et al
JCP
Academic Highlights

October 28, 2014

Rita Suri, Alex S. Lin, Lee S. Cohen, et al

Celebrating
85 Years

Read the Journal of Clinical Psychiatry

Subscribe to read
more articles

Subscribe